Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Expert Opinion on Drug Delivery|December 23, 2006
Paediatric and geriatric drug deliveryJörg Breitkreutz, Joachim BoosHandbook of Experimental Pharmacology|September 2, 2011
Drug delivery and formulationsJörg Breitkreutz, Joachim BoosCancer Chemotherapy and Pharmacology|March 27, 2002
Low dose--high dose: what is the right dose? Pharmacokinetic modeling of etoposideGudrun Würthwein, Joachim BoosJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 27, 2006
Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometryDoris Oechtering, Joachim Boos, Georg HempelJournal of Pediatric Hematology/Oncology|January 7, 2014
Sports in pediatric oncology: the role(s) of physical activity for children with cancerMiriam Götte, Silke Taraks, Joachim BoosCancer Chemotherapy and Pharmacology|February 22, 2005
Interactions of carboxypeptidase G2 with 6S-leucovorin and 6R-leucovorin in vitro: implications for the application in case of methotrexate intoxicationsGeorg Hempel, Rainer Lingg, Joachim BoosAnti-Cancer Drugs|October 21, 2004
In vitro toxicity of bisphosphonates on human neuroblastoma cell linesMarta Vorotnjak, Joachim Boos, Claudia Lanvers-KaminskyExpert Opinion on Drug Metabolism & Toxicology|April 18, 2014
Sources of preanalytical error in pharmacokinetic analyses - focus on intravenous drug administration and collection of blood samplesMiriam Krischke, Alan V Boddy, Joachim BoosCancer Chemotherapy and Pharmacology|January 20, 2016
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitorsViktor Arnhold, Joachim Boos, Claudia Lanvers-KaminskyAnticancer Research|July 5, 2018
Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric MalignanciesEdvin Destanovic, Joachim Boos, Claudia Lanvers-KaminskyPageof 10